Govx stock forecast year-to-date performance for "govx

Year-to-date performance for "govx stock forecast" is down 28%, but historical trend analysis shows recoveries within biotech can be rapid post-positive news. A scientist in a laboratory coat studying a test tube, showing the biotechnology company's clinical-stage therapies. This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Short interest in "govx stock forecast" has declined by 7%, which could reduce selling pressure if sentiment shifts.